Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 20/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1995372 | 0.85 | KIF11 (0.56) | KIF11 | |
| SCHEMBL6434953 | 0.82 | KIF11 (0.57) | KIF11 | |
| SCHEMBL4022115 | 0.81 | KIF11 (0.67) | KIF11 | |
| SCHEMBL10298221 | 0.80 | KIF11 (0.65) | KIF11 | |
| SCHEMBL22612073 | 0.80 | KIF11 (0.65) | KIF11 | |
| SCHEMBL22612075 | 0.80 | KIF11 (0.65) | KIF11 | |
| SCHEMBL22612072 | 0.80 | KIF11 (0.65) | KIF11 | |
| SCHEMBL12086374 | 0.79 | KIF11 (0.54) | KIF11 | |
| SCHEMBL12085934 | 0.79 | KIF11 (0.53) | KIF11 | |
| SCHEMBL38315 | 0.78 | KIF11 (1.00) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10669306-B2 | Solid supports for use in solid-phase peptide synthesis, kits, and related methods | UNIVERSITY OF WASHINGTON (US) | 2020-06-02 | — | — | US | disclosed |
| US-20190010186-A1 | SOLID SUPPORTS FOR USE IN SOLID-PHASE PEPTIDE SYNTHESIS, KITS, AND RELATED METHODS | UNIVERSITY OF WASHINGTON (US) | 2019-01-10 | — | — | US | disclosed |
| US-20120077711-A1 | Novel Ligands and Libraries of Ligands | SUNESIS PHARMACEUTICALS, INC. (US) | 2012-03-29 | — | — | US | disclosed |
| US-20120077711-A1 | Novel Ligands and Libraries of Ligands | SUNESIS PHARMACEUTICALS, INC. (US) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190010186-A1 | SOLID SUPPORTS FOR USE IN SOLID-PHASE PEPTIDE SYNTHESIS, KITS, AND RELATED METHODS | SRM, GSS, SCLY | KIF11 4509/4885 |
| US-10669306-B2 | Solid supports for use in solid-phase peptide synthesis, kits, and related methods | SRM, GSS, SCLY | KIF11 4509/4885 |
| US-20120077711-A1 | Novel Ligands and Libraries of Ligands | LSS, ABCG2, SELL | KIF11 4190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.